Lan-Lan Smith, Editor-in-Chief, Cheryl Lai, Acting Deputy Editor, and Emma Cookson, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between me ...
…
continue reading
Stratis Health Podcasts
The Lancet Haematology launched in Autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice.
…
continue reading
Listen and learn from the lived experience of skilled critical access hospital quality improvement (QI) staff from across the country! These virtual QI mentors will come together periodically for quality time to share PIE—their performance improvement experience. They discuss key themes that help drive quality improvement in their rural hospitals. Listen to their lessons learned, strategies, tips, and ideas. Find valued supportive resources for each of their topics, along with their favorite ...
…
continue reading
1
In conversation with... Yok Lam Kwong, Wee Joo Chng, and Eric Tse
17:58
17:58
Play later
Play later
Lists
Like
Liked
17:58
Authors join us to discuss their recent Series on advances in genomic techniques that have transformed the diagnosis, prognosis, and targeted treatment of mature T-cell and natural killer-cell lymphoma.By The Lancet
…
continue reading
1
A panel of the authors on our Lancet Haematology-Lancet Regional Health Western Pacific Series on mature T-cell and natural killer-cell lymphomas
17:58
17:58
Play later
Play later
Lists
Like
Liked
17:58
Today, on World Lymphoma Awareness Day, Professors Yok Lam Kwong, Wee Joo Chng, and Eric Tse join us in this joint episode of The Lancet Haematology and The Lancet Regional Health - Western Pacific to discuss their recent Series on advances in genomic techniques that have transformed the diagnosis, prognosis, and targeted treatment of mature T-cell…
…
continue reading
1
In conversation with... The Lancet Haematology staff on conference season
19:10
19:10
Play later
Play later
Lists
Like
Liked
19:10
The Lancet Haematology share their thoughts and reflect on their experiences at the European Hematology Association, International Conference on Malignant Lymphoma, and International Society on Thrombosis and Haemostasis meetings.By The Lancet
…
continue reading
1
Lan-Lan Smith, Cheryl Lai, and Daniela Marín discuss the EHA, ICML, and ISTH conferences
19:10
19:10
Play later
Play later
Lists
Like
Liked
19:10
June has been packed with interesting haematology conferences so the editorial team behind The Lancet Haematology have gathered to share their thoughts and reflect on their experiences at the European Hematology Association, International Conference on Malignant Lymphoma, and International Society on Thrombosis and Haemostasis meetings. Read our co…
…
continue reading
Paolo Strati joins us to discuss the results of a multicentre, open-label, phase 1 clinical trial of off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma.By The Lancet
…
continue reading
1
Paolo Strati on off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma
21:49
21:49
Play later
Play later
Lists
Like
Liked
21:49
Associate Professor Paolo Strati (Department of Lymphoma and Myeloma, and Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA) joins us to discuss the results of a multicentre, open-label, phase 1 clinical trial of off-the-shelf induced pluripotent stem-cell-derived natural killer-cell th…
…
continue reading
1
A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies
40:11
40:11
Play later
Play later
Lists
Like
Liked
40:11
With a growing number of treatment options for blood cancers, understanding the side effects from these treatments and how they affect patients is becoming ever more important. Join a panel of authors from The Lancet Haematology's latest series on Adverse Event reporting to discuss how we can improve clinical trial design and analysis, and translat…
…
continue reading
1
A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies
40:11
40:11
Play later
Play later
Lists
Like
Liked
40:11
With a growing number of treatment options for blood cancers, understanding the side effects from these treatments and how they affect patients is becoming ever more important. Join a panel of authors from The Lancet Haematology's latest series on Adverse Event reporting to discuss how we can improve clinical trial design and analysis, and translat…
…
continue reading
Dr Michael Northend (University College London Hospitals NHS Foundation Trust, and Cancer Research UK & UCL Cancer Trials Centre, London, UK) joins us to discuss the long-term results of a randomised, phase 3 trial on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma.…
…
continue reading
1
Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma
15:49
15:49
Play later
Play later
Lists
Like
Liked
15:49
Dr Michael Northend (University College London Hospitals NHS Foundation Trust, and Cancer Research UK & UCL Cancer Trials Centre, London, UK) joins us to discuss the long-term results of a randomised, phase 3 trial on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma. Read th…
…
continue reading
1
In conversation with... Joanne Verweij and Romy Pothof
17:47
17:47
Play later
Play later
Lists
Like
Liked
17:47
Dr Romy Pothof and Prof Joanne Verweij join us to discuss their development of an international consensus on the diagnosis and treatment of fetal and neonatal alloimmune thrombocytopenia.By The Lancet
…
continue reading
1
Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia
17:47
17:47
Play later
Play later
Lists
Like
Liked
17:47
Dr Romy Pothof and Prof Joanne Verweij join us to discuss their development of an international consensus on the diagnosis and treatment of fetal and neonatal alloimmune thrombocytopenia. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00029-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue th…
…
continue reading
1
Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe
27:06
27:06
Play later
Play later
Lists
Like
Liked
27:06
Prof Helene Schoemans, Elke Stienissen, and Kathy Goris join us to discuss the importance of consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedi…
…
continue reading
1
In conversation with... Helene Schoemans, Elke Stienissen, and Kathy Goris
27:06
27:06
Play later
Play later
Lists
Like
Liked
27:06
Prof Helene Schoemans, Elke Stienissen, and Kathy Goris join us to discuss the importance of consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe.By The Lancet
…
continue reading
Dr Dawn Swan joins us to discuss current knowledge and future perspectives on the possible association between air pollution and venous thromboembolism.By The Lancet
…
continue reading
1
Dawn Swan on air pollution and venous thromboembolism
15:02
15:02
Play later
Play later
Lists
Like
Liked
15:02
Dr Dawn Swan joins us to discuss current knowledge and future perspectives on the possible association between air pollution and venous thromboembolism. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00291-6/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhae Continue this conversation on social! Follow u…
…
continue reading
Dr Leslie Skeith joins us to discuss the PARTUM pilot trial, comparing low-dose aspirin versus placebo in postpartum venous thromboembolism.By The Lancet
…
continue reading
1
Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis
16:03
16:03
Play later
Play later
Lists
Like
Liked
16:03
Dr Leslie Skeith joins us to discuss the PARTUM pilot trial, comparing low-dose aspirin versus placebo in postpartum venous thromboembolism. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00338-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us today at..…
…
continue reading
1
In conversation with... Neema Mayor and Caitlin Farrow
17:55
17:55
Play later
Play later
Lists
Like
Liked
17:55
Dr Neema Mayor and Dr Caitlin Farrow from the Anthony Nolan Research Institute join us to discuss the findings of their study on the impact of patient ethnicity on haematopoietic cell transplantation outcomes in the United Kingdom.By The Lancet
…
continue reading
1
Neema Mayor and Caitlin Farrow on impact of patient ethnicity on haematopoeietic cell transplantation outcome in the United Kingdom
17:53
17:53
Play later
Play later
Lists
Like
Liked
17:53
Dr Neema Mayor and Dr Caitlin Farrow from the Anthony Nolan Research Institute join us to discuss the findings of their study on the impact of patient ethnicity on haematopoietic cell transplantation outcomes in the United Kingdom. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00312-0/fulltext?dgcid=buzzs…
…
continue reading
1
Lancet Haematology 10 year anniversary - meet the editors
47:21
47:21
Play later
Play later
Lists
Like
Liked
47:21
In a special 10 year anniversary podcast, Lan-Lan Smith, Yaiza del Pozo Martin, and Emma Cookson, the editorial team behind The Lancet Haematology, reflect on the last decade and give some insights into the editorial processes at The Lancet Group. Read our Editorial: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00289-8/fulltex…
…
continue reading
1
Lancet Haematology 10 year anniversary - meet the editors
47:21
47:21
Play later
Play later
Lists
Like
Liked
47:21
In a special 10 year anniversary podcast, Lan-Lan Smith, Yaiza del Pozo Martin, and Emma Cookson, the editorial team behind The Lancet Haematology, reflect on the last decade and give some insights into the editorial processes at The Lancet Group.By The Lancet
…
continue reading
1
Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome
8:08
8:08
Play later
Play later
Lists
Like
Liked
8:08
Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndrome patients. Continue this conversation on social! Follow us today at... https://thelancet.bsky.soc…
…
continue reading
1
In conversation with... Matteo Giovanni Della Porta
8:08
8:08
Play later
Play later
Lists
Like
Liked
8:08
Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndrome patients.By The Lancet
…
continue reading
Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00166-2?dgcid=buzzsprout_tlv_podcast_generic_lanhae Continue this conversation o…
…
continue reading
Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma.By The Lancet
…
continue reading
1
Judy Truong on ferritin reference levels and iron deficiency
11:17
11:17
Play later
Play later
Lists
Like
Liked
11:17
Dr Judy Truong join us to discuss ferritin reference intervals and how adoption of evidence-based ferritin clinical decision limits can help clinicians detect and treat iron deficiency, minimising propagation of related health inequity and social injustice in medicine. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS235…
…
continue reading
Dr Judy Truong join us to discuss ferritin reference intervals and how adoption of evidence-based ferritin clinical decision limits can help clinicians detect and treat iron deficiency, minimising propagation of related health inequity and social injustice in medicine.By The Lancet
…
continue reading
1
In conversation with... Johannes Schetelig
14:11
14:11
Play later
Play later
Lists
Like
Liked
14:11
Professor Johannes Schetelig joins us to discuss the results of the ASAP phase 3 trial comparing remission induction with immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia.By The Lancet
…
continue reading
1
Johannes Schetelig on remission induction versus immediate allogeneic HSCT for patients with AML
14:11
14:11
Play later
Play later
Lists
Like
Liked
14:11
Professor Johannes Schetelig joins us to discuss the results of the ASAP phase 3 trial comparing remission induction with immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00065…
…
continue reading
Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00078-4?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us toda…
…
continue reading
Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa.By The Lancet
…
continue reading
1
In conversation with... Sabine Braat and Katherine Fielding
18:06
18:06
Play later
Play later
Lists
Like
Liked
18:06
Dr Sabine Braat and Dr Katherine Fielding join us to discuss their study presenting new haemoglobin thresholds for defining anaemia.By The Lancet
…
continue reading
1
Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia
18:06
18:06
Play later
Play later
Lists
Like
Liked
18:06
Dr Sabine Braat and Dr Katherine Fielding join us to discuss their study presenting new haemoglobin thresholds for defining anaemia. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00030-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us today at... https:…
…
continue reading
Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00371-X/fulltext?dgcid=buzzsprout_icw_podcast…
…
continue reading
Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation.By The Lancet
…
continue reading
Professor Stephan Ehl joins us to discuss a prospective observational study on paediatric autoimmune lymphoproliferative immunodeficiencies.By The Lancet
…
continue reading
1
Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies
13:03
13:03
Play later
Play later
Lists
Like
Liked
13:03
Professor Stephan Ehl joins us to discuss a prospective observational study on paediatric autoimmune lymphoproliferative immunodeficiencies. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00638-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc Continue this conversation on social! Follow us today at..…
…
continue reading
Dr Sarah O'Brien joins Lan-Lan Smith to discuss results of the phase 3 PREVAPIX-ALL trial, which compares direct oral anticoagulant apixaban to low-molecular-weight-heparin for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma.By The Lancet
…
continue reading
1
Dr Sarah O'Brien on the PREVAPIX-ALL trial
13:50
13:50
Play later
Play later
Lists
Like
Liked
13:50
Dr Sarah O'Brien joins Lan-Lan Smith to discuss results of the phase 3 PREVAPIX-ALL trial, which compares direct oral anticoagulant apixaban to low-molecular-weight-heparin for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma. Read the full article: https://www.thelancet.com/journal…
…
continue reading
Professor Enrico Lopriore joins us to discuss a trial testing darbepoetin alfa to prevent postnatal anaemia in infants with haemolytic disease of the fetus and newborn.By The Lancet
…
continue reading
1
Enrico Lopriore on haemolytic disease of the fetus and newborn
12:33
12:33
Play later
Play later
Lists
Like
Liked
12:33
Professor Enrico Lopriore joins us to discuss a trial testing darbepoetin alfa to prevent postnatal anaemia in infants with haemolytic disease of the fetus and newborn. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00285-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on …
…
continue reading
Professor Meletios Dimopoulos joins us to discuss two trials for patients with relapsed and refractory multiple myeloma - the first report of the DREAMM-3 phase 3 and long-term follow-up of the APOLLO phase 3 trial.By The Lancet
…
continue reading
1
Meletios Dimopoulos on relapsed and refractory multiple myeloma
11:00
11:00
Play later
Play later
Lists
Like
Liked
11:00
Professor Meletios Dimopoulos joins us to discuss two trials for patients with relapsed and refractory multiple myeloma - the first report of the DREAMM-3 phase 3 and long-term follow-up of the APOLLO phase 3 trial. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00243-0/fulltext?dgcid=buzzsprout_icw_podcas…
…
continue reading
Dr Eric Ohuma joins us to tell us about a study recently published in The Lancet Haematology on the association between maternal haemoglobin concentrations and maternal and neonatal outcomes.By The Lancet
…
continue reading
1
Eric Ohuma on haemoglobin concentrations and neonatal outcomes
16:27
16:27
Play later
Play later
Lists
Like
Liked
16:27
Dr Eric Ohuma joins us to tell us about a study recently published in The Lancet Haematology on the association between maternal haemoglobin concentrations and maternal and neonatal outcomes. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00170-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continu…
…
continue reading
1
QI Mentor Conversation: Improving Swing Bed Quality
17:15
17:15
Play later
Play later
Lists
Like
Liked
17:15
In this session of Quality Time: Sharing PIE, mentors Kathe Bryant from Covington County Hospital in Collins, Mississippi, and Cara Cruz from Carson Valley Medical Center (CVMC) in Gardnerville, Nevada, share the proactive approaches they took to improve their swing bed programs.
…
continue reading
1
QI Mentor Conversation: Preventing Readmissions
21:21
21:21
Play later
Play later
Lists
Like
Liked
21:21
In this session of Quality Time: Sharing PIE, mentors Tammy Sudtelgte from Floyd Valley Healthcare in Le Mars, Iowa, Stacey Karvoski from Wallowa Memorial Hospital in Enterprise, Oregon, and Linda Webb from Pulaski Memorial Hospital in Winamac, Indiana share their varied approaches their teams have used to reduce avoidable hospital readmissions.…
…
continue reading
Professor Margaret Ragni joins us to discuss the VWDMin study, published in The Lancet Haematology. In this phase 3, randomised, crossover trial, recombinant von Willebrand factor and tranexamic acid are used to treat heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA.…
…
continue reading
1
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding
13:13
13:13
Play later
Play later
Lists
Like
Liked
13:13
Professor Margaret Ragni joins us to discuss the VWDMin study, published in The Lancet Haematology. In this phase 3, randomised, crossover trial, recombinant von Willebrand factor and tranexamic acid are used to treat heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA. Read the full article: https://www.th…
…
continue reading
